RAMM Pharma

RAMM Pharma Long-term Debt

The Long-Term Debt of RAMM Pharma (RAMM.CN) as of Oct 30, 2026 is 1.37 M CAD.

Long-term Debt

1.37 MCAD

Last updated:

Long-Term Debt of RAMM Pharma is 2018 1.37 M CAD. Long-Term Debt of RAMM Pharma was 2017 - CAD. It decreases by % lower compared to the previous year.

The RAMM Pharma Long-term Debt history

The RAMM Pharma Long-term Debt history
YEARLong-term DebtYoY
1.37 MCAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RAMM Pharma Stock analysis

What does RAMM Pharma do? RAMM Pharma Corp generates revenue through cannabinoid pharmaceuticals and cannabis-based products, with brands like NettaLife, NettaPet, NettaPet Senior, NettaPet Puppies, and NettaVet targeting pet owners and veterinary markets. The company also sells cosmetics under the Cannabipiel line, including Cannabipiel Nite, Cannabipiel Body Lotion, and Cannabipiel Shampoo, catering to consumers seeking cannabinoid-infused skincare and personal care solutions. Subsidiaries such as Canapar Corp. and Medic Plast SA support production and commercialization across pharmaceutical specialties, household products, and food sectors. The firm’s product portfolio spans pharmaceuticals, pet care, cosmetics, and household items, with NettaPet and NettaVet focusing on animal health and Cannabipiel products targeting human skincare. Revenue streams include direct sales of branded items like Cannabipiel Tite and Cannabipiel Cleaning Emulsion to retail and specialty markets, while subsidiaries handle manufacturing and export operations for global distribution. Brands like Glediser SA and Yurelan SA contribute to the commercialization of diverse product categories under the company’s umbrella. RAMM Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RAMM Pharma stock

Long-Term Debt of RAMM Pharma is 1.37 M CAD in 2018.

On Eulerpool you can find the complete historical development of Long-Term Debt RAMM Pharma since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's RAMM Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — RAMM Pharma

All Key Metrics — RAMM Pharma